Skip to content

Rehabilitation for cardiac arrhythmia

Rehabilitation for cardiac arrhythmia in COVID-19 and non-COVID-19 patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN11721294
Enrollment
110
Registered
2021-08-13
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation Circulatory System Atrial fibrillation

Interventions

Stage 1: Part a. eligible patients will be contacted to answer a survey by phone, they will be asked about their AF symptoms, their perception and preference to rehabilitation programm

Sponsors

University Hospitals of Leicester NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: For stage 1: 1. 18 years or older 2. Have a clinical diagnosis of AF and awaiting ablation 4. Able to exercise and understand exercise instructions 5. Able to speak and read English 6. Willing and able to provide informed consent for participation in the study For stage 2: 1. 18 years or older 2. Health care professionals who are involved in the care for patients with AF 3. Willing and able to provide informed consent for participation in the study For stage 3 (the observational study): 1. 18 years or older 2. Have a clinical diagnosis of COVID-19 3. Enrolling into post COVID-19 rehabilitation programme 4. Able to speak and read English 5. Willing and able to provide informed consent for participation in the study

Exclusion criteria

Exclusion criteria: For stage 3: 1. Patients with known AF or any type of arrhythmia 2. Patients using beta blockers

Design outcomes

Primary

MeasureTime frame
Autonomic function measured using 12-Leads NORAV ECG Holter device to record the heart activity for 10 minutes and 24 hours at baseline and after rehabilitation programme (6 weeks)

Secondary

MeasureTime frame
1. Physical activity (using GT3x Actigraph) for seven days before starting the programme and in the last week of the programme We will assess the following outcome measures which are routinely collected at baseline and after 6-weeks of the programme: 2. Health related quality of life by using The EuroQual 5 domain (EQ5D) 3. Exercise capacity by using incremental shuttle walking test (ISWT) 4. Disease symptoms by using COPD Assessment Test (CAT) 5. Fatigue by using Functional Assessment Chronic Illness Therapy Fatigue scale (FACIT-FS) 6. Anxiety and mental health will be measured by using the Hospital Anxiety and Depression Scale (HADS) For stage 1&2 of the study: 1. Patients attitude and expectation toward rehabilitation programme will be assessed using surveys and qualitative interviews. 2. Health care professionals attitude and expectation toward rehabilitation programme will be assessed using surveys and qualitative interviews.

Countries

England, United Kingdom

Contacts

Public ContactMunyra Alhotye
ma880@leicester.ac.uk+44 (0)7311 661834

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026